Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/11/2021
SK Biopharm Establishes Biotech Company in China
11/11/2021
AffaMed Launches Digital Medicines Unit
11/11/2021
PharmExec: China 2021 National Reimbursement Drug List Outlook (Update...
11/11/2021
How Hong Kong Plays a Central Role in The Biotech Investment Boom
11/10/2021
South China Province Plans $94 Million HPV Vaccination Pilot Program
11/10/2021
NDRC and MIIT Jointly Issue the Implementation Plan for Promoting High...
11/10/2021
Eli Lilly's Chinese NDA for RET Inhibitor Selpercatinib Accepted
11/10/2021
CDR Solicits Comments for the Proposed Guidelines for Preparing Drug P...
11/10/2021
CPhI Survey: US Pharma Growth to Exceed Both India and China in 2022
11/10/2021
Merck KGaA Veteran Launches I/O Startup Marengo Therapeutics with $80M
11/9/2021
Biosynth Carbosynth and Shengquan Acquire Kexing Biopharma's API Plant
11/9/2021
PhIIC Reports Topline 2020 Data of Chinese Pharmaceutical Market
11/9/2021
HUYABIO Announces the Exclusive License of the Wee1 Inhibitor from Sha...
11/9/2021
China Reports Progress of New COVID-19 Antibody Drugs
11/9/2021
Incidence of Guillain-Barré Syndrome (GBS) in China: A National Popul...
11/8/2021
I-Mab and Roche Diagnostics Announce Strategic Collaboration to Co-Dev...
11/8/2021
Ascentage and Pfizer Enter Clinical Trial Agreement to Evaluate Lisaft...
11/8/2021
NHC Issues Action Plan to Improve Child Health
11/8/2021
Half of Top 20 Pharma MNCs Participate CIIE, Showing Continued Commitm...
11/8/2021
GlobalData: China's Accelerated Drug Approval Path Decelerate vs Other...
11/8/2021
Nippon Shinyaku Establishes a Local Subsidiary in China
11/8/2021
FT: US and China Urged to Collaborate on Cancer Drugs through New Init...
11/8/2021
HitGen Teams Up with Cambridge Molecular for 'Deep Learning' Drug Dis...
11/8/2021
ZJ Biotech and Boehringer Sign Biopharma Partnership at CIIE
11/5/2021
CDE Solicits Comments on the Draft Measures for Suspension and Resumpt...
11/5/2021
Recent Executive Moves
11/5/2021
Biopharma Giant MSD Embraces New Opportunities at CIIE
11/5/2021
Roche Showcases Cutting-Edge Healthcare Innovation Solutions at CIIE
11/4/2021
NMPA Withdraws Approvals of 34 Domestic and Foreign Drug Products
11/4/2021
MOFCOM Issues the Guidance Opinions for High Quality Development of th...
Page:
162
/
774
Total number of articles:
23207
:
[First]
[<<]
[160]
[161]
[162]
[163]
[164]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit